Humacyte, Inc. (HUMA) Social Stream



Humacyte, Inc. (HUMA): $3.07

-0.02 (-0.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HUMA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

HUMACYTE INC (HUMA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HUMACYTE INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $20 $16 $17.8 $3.2 456.25%
2022-01-31 6 $20 $16 $17.8 $3.2 456.25%
2022-02-01 6 $20 $12 $16.8 $3.2 425%
2022-03-31 5 $19 $10 $15 $3.2 368.75%
2022-05-16 5 $19 $4 $13.8 $3.2 331.25%
2022-05-17 5 $19 $4 $13 $3.2 306.25%
2022-08-15 5 $18 $4 $11.2 $3.2 250%
2022-11-11 4 $18 $2.75 $8.75 $3.2 173.44%
2022-11-15 5 $18 $2.75 $8.75 $3.2 173.44%

The Trend in the Analyst Price Target


Over the past 13 months, HUMA's average price target has gone down $9.05.

Over the past 41 weeks, HUMA's average upside potential has been 159.79%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-01 6 20 12.0 16.800 5.53 203.8%
2022-02-01 6 20 12.0 17.000 5.53 207.41%
2022-03-31 6 20 10.0 15.833 7.06 124.26%
2022-08-15 5 18 3.5 9.500 4.78 98.74%
2022-08-15 4 18 4.0 11.200 4.78 134.31%

HUMA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.8 4 0 0 1 1 5

The Trend in the Broker Recommendations


Over the past 14 months, HUMA's average broker recommendation rating improved by 0.2.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HUMA as an investment opportunity.

  • In terms of how HUMACYTE INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1123.35% of that group.
  • In terms of how HUMACYTE INC fares relative to all US stocks, note that its average analyst price target is higher than 202.42% of that group.
  • In terms of how HUMACYTE INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -857.36% of that group.
  • In terms of how HUMACYTE INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 446.52% of that group.

Stocks similar to HUMACYTE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TSHA, CDAK, and OPT.

Is HUMA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5777 seconds.